Literature DB >> 9366419

HLA-DP2: self peptide sequences and binding properties.

R M Chicz1, D F Graziano, M Trucco, J L Strominger, J C Gorga.   

Abstract

Although self peptides bound to HLA-DQ and, especially, HLA-DR allotypes have been described in some detail, few ligands that bind to HLA-DP have been identified. Toward this aim, naturally processed peptides were isolated from immunoaffinity-purified HLA-DP2 molecules expressed in cultured B lymphocytes. The size distribution of the peptide repertoire is generally similar to those reported for self peptides bound to HLA-DR and HLA-DQ molecules. Twelve peptides representing individual sequences including two nested sets were sequenced by mass spectrometry and/or N-terminal Edman analysis. Source proteins included MHC molecules and other integral membrane proteins as well as secretory and serum proteins. No dominant amino acid markers suggestive of particular enzymatic processing events were detected. Peptide specificity and affinity were examined in binding assays using synthetic peptides and purified HLA-DP and HLA-DR molecules. Anchor residues were tentatively assigned using alanine-substituted analogues of two self peptides. Some structural features of HLA-DP2 that may relate to peptide binding are considered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366419

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  HLA-DP, HLA-DQ, and HLA-DR have different requirements for invariant chain and HLA-DM.

Authors:  Marcel van Lith; Rosanna M McEwen-Smith; Adam M Benham
Journal:  J Biol Chem       Date:  2010-10-19       Impact factor: 5.157

2.  Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs.

Authors:  Gema Díaz; Benito Cañas; Jesús Vazquez; César Nombela; Javier Arroyo
Journal:  Immunogenetics       Date:  2004-11-24       Impact factor: 2.846

3.  Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease.

Authors:  A P Fontenot; M Torres; W H Marshall; L S Newman; B L Kotzin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

4.  Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4.

Authors:  M Peakman; E J Stevens; T Lohmann; P Narendran; J Dromey; A Alexander; A J Tomlinson; M Trucco; J C Gorga; R M Chicz
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

6.  HLA genotypes and rubella vaccine immune response: additional evidence.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Beth R Larrabee; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2014-05-15       Impact factor: 3.641

7.  Predicting HLA class II antigen presentation through integrated deep learning.

Authors:  Binbin Chen; Michael S Khodadoust; Niclas Olsson; Lisa E Wagar; Ethan Fast; Chih Long Liu; Yagmur Muftuoglu; Brian J Sworder; Maximilian Diehn; Ronald Levy; Mark M Davis; Joshua E Elias; Russ B Altman; Ash A Alizadeh
Journal:  Nat Biotechnol       Date:  2019-10-14       Impact factor: 54.908

8.  Peptide binding prediction for the human class II MHC allele HLA-DP2: a molecular docking approach.

Authors:  Atanas Patronov; Ivan Dimitrov; Darren R Flower; Irini Doytchinova
Journal:  BMC Struct Biol       Date:  2011-07-14

9.  Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses.

Authors:  Victoria A Brentville; Rachael L Metheringham; Ian Daniels; Suha Atabani; Peter Symonds; Katherine W Cook; Mireille Vankemmelbeke; Ruhul Choudhury; Poonam Vaghela; Mohamed Gijon; Ghislaine Meiners; Willem-Jan Krebber; Cornelis J M Melief; Lindy G Durrant
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

10.  HLA-associated susceptibility to childhood B-cell precursor ALL: definition and role of HLA-DPB1 supertypes.

Authors:  G M Taylor; A Hussain; T J Lightfoot; J M Birch; T O B Eden; M F Greaves
Journal:  Br J Cancer       Date:  2008-03-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.